Rockefeller Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Rockefeller Capital Management's FBT Position: Q1 2026 in Review
Rockefeller Capital Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 235% in Q1 2026, buying an estimated $2.05M and bringing the position to 14,134 shares worth $2.84M. The position accounts for 0.01% of the portfolio, ranked #1144.
Rockefeller Capital Management first reported a position in FBT in Q1 2019 and has held it in 21 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Rockefeller Capital Management held 14,134 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.84M as of Q1 2026.
- Rockefeller Capital Management bought 9,915 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.05M.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1144 holding.
- Rockefeller Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 21 quarters since.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.